Emily Fisher

Statistics

Publications

Citations

239

H-Index

Active since

1998

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

University of Michigan

Johns Hopkins University

SWOG Cancer Research Network

Wichita Clinic

Emily Fisher is an author at The Barbara Ann Karmanos Cancer Institute specializing in oncology, prostate cancer, and genitourinary cancer pharmacotherapy.

Publications per year

1998–2001

Publications

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)

Ömer Küçük, Emily Fisher, Carol M. Moinpour et al. · Urology · 2001 · 99 citations

Medicine, Oncology, Urology +16

Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916.

Maha Hussain, Daniel P. Petrylak, Emily Fisher et al. · PubMed · 1999 · 47 citations

Medicine, Oncology, Urology +14

13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon-α in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial

Geoffrey R. Weiss, P. Y. Liu, David S. Alberts et al. · Gynecologic Oncology · 1998 · 35 citations

Medicine, Gynecology, Oncology +13

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)

Kenneth J. Pienta, Emily Fisher, Mario A. Eisenberger et al. · The Prostate · 2001 · 29 citations

Pharmacy, Oncology, Pharmacotherapy +16

Androgen Deprivation and Four Courses of Fixed-Schedule Suramin Treatment in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Southwest Oncology Group Study

Maha Hussain, Emily Fisher, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2000 · 29 citations

Medicine, Oncology, Pharmacology +16

1–5 of 5